Table 1. Multiparametric In-vitro Cardiotoxicity Testing Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Multiparametric In-vitro Cardiotoxicity Testing Market Restraints

Table 3. Multiparametric In-vitro Cardiotoxicity Testing Market Trends

Table 4. Multiparametric In-vitro Cardiotoxicity Testing Industry Policy

Table 5. Global Multiparametric In-vitro Cardiotoxicity Testing Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share by Company (2019-2024)

Table 7. Global Multiparametric In-vitro Cardiotoxicity Testing Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Multiparametric In-vitro Cardiotoxicity Testing Mergers & Acquisitions, Expansion Plans

Table 9. Global Multiparametric In-vitro Cardiotoxicity Testing Manufacturers Product Type

Table 10. China Multiparametric In-vitro Cardiotoxicity Testing Revenue by Company (2019-2024) & (US$ million)

Table 11. China Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing Upstream (Raw Materials)

Table 13. Global Multiparametric In-vitro Cardiotoxicity Testing Typical Customers

Table 14. Multiparametric In-vitro Cardiotoxicity Testing Typical Distributors

Table 15. By Type of Assay, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Multiparametric In-vitro Cardiotoxicity Testing Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2030

Table 22. Creative Bioarray Company Information, Head Office, Market Area and Industry Position

Table 23. Creative Bioarray Company Profile and Main Business

Table 24. Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 25. Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 26. Creative Bioarray Recent Developments

Table 27. Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position

Table 28. Agilent Technologies, Inc. Company Profile and Main Business

Table 29. Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 30. Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 31. Agilent Technologies, Inc. Recent Developments

Table 32. Hemogenix Inc. Company Information, Head Office, Market Area and Industry Position

Table 33. Hemogenix Inc. Company Profile and Main Business

Table 34. Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 35. Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 36. Hemogenix Inc. Recent Developments

Table 37. Merck KGaA Company Information, Head Office, Market Area and Industry Position

Table 38. Merck KGaA Company Profile and Main Business

Table 39. Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 40. Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 41. Merck KGaA Recent Developments

Table 42. Molecular Devices, LLC. Company Information, Head Office, Market Area and Industry Position

Table 43. Molecular Devices, LLC. Company Profile and Main Business

Table 44. Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 45. Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 46. Molecular Devices, LLC. Recent Developments

Table 47. Miltenyi Biotec Company Information, Head Office, Market Area and Industry Position

Table 48. Miltenyi Biotec Company Profile and Main Business

Table 49. Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 50. Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 51. Miltenyi Biotec Recent Developments

Table 52. FUJIFILM Cellular Dynamics Company Information, Head Office, Market Area and Industry Position

Table 53. FUJIFILM Cellular Dynamics Company Profile and Main Business

Table 54. FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 55. FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 56. FUJIFILM Cellular Dynamics Recent Developments

Table 57. Enzo Life Sciences, Inc. Company Information, Head Office, Market Area and Industry Position

Table 58. Enzo Life Sciences, Inc. Company Profile and Main Business

Table 59. Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 60. Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 61. Enzo Life Sciences, Inc. Recent Developments

Table 62. Axol Bioscience Ltd. Company Information, Head Office, Market Area and Industry Position

Table 63. Axol Bioscience Ltd. Company Profile and Main Business

Table 64. Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 65. Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 66. Axol Bioscience Ltd. Recent Developments

Table 67. emka TECHNOLOGIES Company Information, Head Office, Market Area and Industry Position

Table 68. emka TECHNOLOGIES Company Profile and Main Business

Table 69. emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 70. emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 71. emka TECHNOLOGIES Recent Developments

Table 72. Eurofins Discovery Company Information, Head Office, Market Area and Industry Position

Table 73. Eurofins Discovery Company Profile and Main Business

Table 74. Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 75. Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 76. Eurofins Discovery Recent Developments

Table 77. Stemina Biomarker Discovery, Inc. Company Information, Head Office, Market Area and Industry Position

Table 78. Stemina Biomarker Discovery, Inc. Company Profile and Main Business

Table 79. Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 80. Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 81. Stemina Biomarker Discovery, Inc. Recent Developments

Table 82. Evotec Company Information, Head Office, Market Area and Industry Position

Table 83. Evotec Company Profile and Main Business

Table 84. Evotec Multiparametric In-vitro Cardiotoxicity Testing Models, Specifications and Application

Table 85. Evotec Multiparametric In-vitro Cardiotoxicity Testing Revenue and Gross Margin, 2019-2024

Table 86. Evotec Recent Developments

List of Figure

Figure 1. Multiparametric In-vitro Cardiotoxicity Testing Picture

Figure 2. Global Multiparametric In-vitro Cardiotoxicity Testing Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Multiparametric In-vitro Cardiotoxicity Testing Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Multiparametric In-vitro Cardiotoxicity Testing Market Share of Global

Figure 5. Global Multiparametric In-vitro Cardiotoxicity Testing Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Multiparametric In-vitro Cardiotoxicity Testing Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Multiparametric In-vitro Cardiotoxicity Testing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Multiparametric In-vitro Cardiotoxicity Testing Industry Chain

Figure 10. Calcium Transient Assay

Figure 11. Cardiac Marker Detection

Figure 12. hERG Assay

Figure 13. Multi-ion Channel Assay

Figure 14. Others

Figure 15. By Type of Assay, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, US$ Million

Figure 16. By Type of Assay, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2030

Figure 17. Contract Research Organizations (CROs)

Figure 18. Pharmaceutical and Biotech Companies

Figure 19. Others

Figure 20. By Application, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, US$ Million

Figure 21. By Application, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2030

Figure 22. By Region, Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2030

Figure 23. North America Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts, 2019-2030, US$ Million

Figure 24. By Country, North America Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2024

Figure 25. Europe Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts, 2019-2030, US$ Million

Figure 26. By Country, Europe Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2024

Figure 27. Asia Pacific Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts, 2019-2030, US$ Million

Figure 28. By Country/Region, Asia Pacific Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2024

Figure 29. South America Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts, 2019-2030, US$ Million

Figure 30. By Country, South America Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2019-2024

Figure 31. Middle East & Africa Multiparametric In-vitro Cardiotoxicity Testing Revenue & Forecasts, 2019-2030, US$ Million

Figure 32. U.S. Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 33. By Company, U.S. Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 34. By Type of Assay, U.S. Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 35. By Application, U.S. Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 36. Europe Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 37. By Company, Europe Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 38. By Type of Assay, Europe Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 39. By Application, Europe Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 40. China Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 41. By Company, China Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 42. By Type of Assay, China Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 43. By Application, China Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 44. Japan Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 45. By Company, Japan Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 46. By Type of Assay, Japan Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 47. By Application, Japan Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 48. South Korea Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 49. By Company, South Korea Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 50. By Type of Assay, South Korea Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 51. By Application, South Korea Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 52. Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 53. By Company, Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 54. By Type of Assay, Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 55. By Application, Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 56. India Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 57. By Company, India Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 58. By Type of Assay, India Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 59. By Application, India Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 60. Middle East & Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue, 2019-2030, (US$ Million)

Figure 61. By Company, Middle East & Asia Multiparametric In-vitro Cardiotoxicity Testing Market Share, 2019-2024

Figure 62. By Type of Assay, Middle East & Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 63. By Application, Middle East & Asia Multiparametric In-vitro Cardiotoxicity Testing Revenue Market Share, 2022 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches